Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference

Core Insights - Axogen, Inc. is a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function [1] - The company will participate in the J.P. Morgan 2026 Healthcare Conference on January 15, 2026, at 10:30 AM Pacific Standard Time [2] Company Overview - Axogen focuses on the science, development, and commercialization of technologies for peripheral nerve repair, aiming to make nerve repair the expected standard of care [3] - The company's product portfolio includes Avance® (acellular nerve allograft-arwx), Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, and Avive+ Soft Tissue Matrix™ [4] - Axogen's products are available in multiple countries, including the United States, Canada, Germany, the United Kingdom, and Spain [4]